LCB
Live / Registered — Registered (as of 06 Jan 2026)
What this means for you
Registered since 06 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98921341
- Registration number
- 8091682
- Mark type
- Word mark
- Filed
- 24 Dec 2024
- Published for opposition
- 21 Oct 2025
- Registered
- 06 Jan 2026
- Attorney of record
- Richard Y. Kim
Goods and services
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug development, namely, pharmaceutical drug development services in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and pharmaceutical research services; research in the field of medical preparations; medical research laboratory services; medicine research, namely, medical research services relating to medicines in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; providing PAAS (platform as a service) featuring computer software used to conduct research and development in the field of pharmaceuticals, biotechnology and drugs; laboratory research services relating to pharmaceuticals; Technology research in the field of medical instruments; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical research and analysis
Owner
- LigaChem Biosciences Inc., Yuseong-gu, Daejeon, KR
- LigaChem Biosciences Inc., Yuseong-gu, Daejeon, KR
- LigaChem Biosciences Inc., Yuseong-gu, Daejeon, KR
Prosecution history
- 06 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 18 Dec 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 18 Dec 2025 — NOTICE OF ALLOWANCE CANCELLED
- 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Dec 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 05 Dec 2025 — ASSIGNED TO PETITION STAFF
- 20 Oct 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Oct 2025 — PUBLISHED FOR OPPOSITION
- 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED